Search research articles
Contact Us
Filters
Showing results (141-150 of 143) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 143 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Cancer Discovery
|
June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 143) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 143 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Cancer Discovery
|
June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Page
of 15